Targeting Ligand Specificity Linked to Tumor Tissue Topological Heterogeneity via Single-Cell Micro-Pharmacological Modeling
Autor: | Tingan Chen, David L. Morse, Amanda S. Huynh, Veronica Estrella, Aleksandra Karolak, Josef Vagner, Katarzyna A. Rejniak |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2018 |
Předmět: |
0301 basic medicine
medicine.medical_treatment Cell lcsh:Medicine Mice SCID Article Targeted therapy Mice 03 medical and health sciences Drug Delivery Systems 0302 clinical medicine In vivo Cell Line Tumor medicine Animals Humans Distribution (pharmacology) Receptor lcsh:Science Multidisciplinary Ligand Chemistry lcsh:R Models Theoretical Tumor tissue 3. Good health Pancreatic Neoplasms 030104 developmental biology medicine.anatomical_structure Microscopy Fluorescence 030220 oncology & carcinogenesis Cancer research lcsh:Q Preclinical imaging |
Zdroj: | Scientific Reports, Vol 8, Iss 1, Pp 1-14 (2018) Scientific Reports |
ISSN: | 2045-2322 |
DOI: | 10.1038/s41598-018-21883-z |
Popis: | Targeted therapy has held promise to be a successful anticancer treatment due to its specificity towards tumor cells that express the target receptors. However, not all targeting drugs used in the clinic are equally effective in tumor eradication. To examine which biochemical and biophysical properties of targeted agents are pivotal for their effective distribution inside the tumor and their efficient cellular uptake, we combine mathematical micro-pharmacological modeling with in vivo imaging of targeted human xenograft tumors in SCID mice. The mathematical model calibrated to experimental data was used to explore properties of the targeting ligand (diffusion and affinity) and ligand release schemes (rates and concentrations) with a goal to identify the properties of cells and ligands that enable high receptor saturation. By accounting for heterogeneities typical of in vivo tumors, our model was able to identify cell- and tissue-level barriers to efficient drug uptake. This work provides a base for utilizing experimentally measurable properties of a ligand-targeted agent and patient-specific attributes of the tumor tissue to support the development of novel targeted imaging agents and for improvement in their delivery to individual tumor cells. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |